Eric Topol

It seems like you've been doing that.

Now, we're also in a very unique era where

this kind of large language of life models, so many things that are fulfilling this kind of digital biology or biology becoming an engineering discipline in many respects.

And your work exemplifies that.

So things are really taking off in terms of this

not just the language of life, but being able to understand a person's life and health on a basis that we probably might not have thought about.

you know, a few years ago, maybe even a few months ago.

So where do we go from here?

I guess just to sum up, you're pursuing the clinical path for the protein sensor.

Maybe you'll be able to get into people in a year and a half, perhaps.

Is that fair?

Right.

And I'm signing myself up to be the first one.

That'd be exciting.

Yeah, what you're doing is really extraordinary.

I just want to congratulate you on that.

And if there's any questions before we wrap up, this is a good time to put them in the message.

Somebody did ask about colchicine.

Like, for example, if you have atherosclerosis,

and you had inflammation and you're denoting artery inflammation, would you be able to see whether the medications are bringing down the inflammation?